Table-II.
Group | Observation time | Pelvic symptom score | Clinical sign score | |||
---|---|---|---|---|---|---|
Dysmenorrhea | Dyspareunia | Pelvic pain | Pelvic tenderness | Induration | ||
Control | Before treatment | 6.55±1.14 | 6.11±1.21 | 6.65±1.34 | 5.46±1.33 | 6.02±1.25 |
After treatment | 2.35±1.01* | 1.79±0.72* | 2.11±0.57* | 2.11±0.51* | 2.11±0.56* | |
Treatment | Before treatment | 6.75±0.94 | 6.27±1.03 | 6.49±1.23 | 5.77±1.22 | 6.05±1.33 |
After treatment | 0.59±0.24*# | 0.72±0.24*# | 0.71±0.17*# | 0.79±0.21*# | 0.89±0.51*# |
Compared with the same group before treatment:
P<0.05; compared with the control group after treatment:
P<0.05.